• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Sotac Share Price

    Sotac Pharmaceuticals Ltd Share PriceSotac Pharmaceuticals Ltd

    Small Cap Result
    ₹120.00
    -2 (-1.64%)
    As on 25 September, 2023 | 14:58 BSE: NSE: SOTACISIN: INE0O2D01012

    Sotac Pharmaceuticals Ltd Performance

    Day Range

    • Low 120
    • High 120
    120.00

    52 Week Range

    • Low 110
    • High 148.9
    120.00
    • Open Price120
    • Previous Close122
    • Volume1200

    Start SIP in Sotac Pharmaceuticals Ltd

    Start SIP

    Sotac Pharmaceuticals Ltd Share Price

    • Over 1 Month -4.91%
    • Over 3 Month -2.44%

    Sotac Pharmaceuticals Ltd Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 133
    Price to Book Ratio 13
    EPS 4.1
    Dividend 0
    Relative Strength Index 45.81
    Money Flow Index 39.2
    MACD Signal 0.25
    Average True Range 3.8

    Sotac Pharmaceuticals Ltd Investment Rating

    • Master Rating:

    • Sotac Pharmaceuticals Ltd has an operating revenue of Rs. 136.07 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 5% is okay, ROE of 22% is exceptional. The company has a debt to equity of 78%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 102 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    N/A

    Price Strength

    Buyer Demand

    Group Rank

    Sotac Pharmaceuticals Ltd Financials
    IndicatorJun 2023Mar 2023Jun 2022
    Oper Rev Qtr Cr 191315
    Operating Expenses Qtr Cr 171112
    Operating Profit Qtr Cr 223
    Depreciation Qtr Cr 000
    Interest Qtr Cr 000
    Tax Qtr Cr 011
    Net Profit Qtr Cr 112
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 5873
    Operating Expenses Annual Cr 5067
    Operating Profit Annual in Cr 86
    Depreciation Cr 21
    Interest Annual Cr 11
    Tax Annual Cr 12
    Net Profit Annual Cr 43
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 96
    Cash from Investing Activity Annual Cr -11-4
    Cash from Financing Annual Activity Cr 12-3
    Net Cash Flow Annual Cr 100
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 127
    Fixed Assets Annual Cr 149
    Total Non Current Assets Annual Cr 189
    Total Current Assets Annual Cr 3726
    Total Assets Annual Cr 5535
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 1429
    ROE Annual % 3943
    ROCE Annual % 2568
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 159
    IndicatorJun 2023Mar 2023Jun 2022
    Oper Rev Qtr Cr 251820
    Operating Expenses Qtr Cr 231618
    Operating Profit Qtr Cr 222
    Depreciation Qtr Cr 110
    Interest Qtr Cr 010
    Tax Qtr Cr 101
    Net Profit Qtr Cr 111
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 7873
    Operating Expenses Annual Cr 7067
    Operating Profit Annual in Cr 76
    Depreciation Cr 21
    Interest Annual Cr 21
    Tax Annual Cr 22
    Net Profit Annual Cr 23
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 86
    Cash from Investing Activity Annual Cr -12-4
    Cash from Financing Annual Activity Cr 13-3
    Net Cash Flow Annual Cr 100
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 107
    Fixed Assets Annual Cr 249
    Total Non Current Assets Annual Cr 279
    Total Current Assets Annual Cr 4726
    Total Assets Annual Cr 7435
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 1329
    ROE Annual % 2343
    ROCE Annual % 1968
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 109

    Sotac Pharmaceuticals Ltd Technicals

    EMA & SMA

    Current Price
    ₹120.00
    -2 (-1.64%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 11
    • 20 Day
    • ₹122.81
    • 50 Day
    • ₹122.6
    • 100 Day
    • ₹
    • 200 Day
    • ₹
    • 20 Day
    • ₹123.6
    • 50 Day
    • ₹121.65
    • 100 Day
    • ₹
    • 200 Day
    • ₹

    Sotac Pharmaceuticals Ltd Resistance and Support

    PIVOT
    ₹120.
    Resistance
    First Resistance ₹120
    Second Resistance ₹120
    Third Resistance ₹120
    RSI 45.81
    MFI 39.21
    MACD Single Line 0.25
    MACD -0.4
    Support
    First Resistance ₹120
    Second Resistance ₹120
    Third Resistance ₹120

    Sotac Pharmaceuticals Ltd Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,200 120,000 100
    Week 1,200 120,000 100
    1 Month 18,320 1,808,001 98.69
    6 Month 22,597 2,210,416 97.82

    Sotac Pharmaceuticals Ltd Result Highlights

    Sotac Pharmaceuticals Ltd Synopsis

    NSE-Medical-Biomed/Biotech

    Sotac Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 57.98 Cr. and Equity Capital is Rs. 8.05 Cr. for the Year ended 31/03/2023. Sotac Pharmaceuticals Ltd is a Public Limited Listed company incorporated on 18/12/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24230GJ2015PLC085451 and registration number is 085451.
    Market Cap 133
    Sales 32
    Shares in Float 0.30
    No of funds 4
    Yield
    Book Value 8.39
    U/D Vol ratio 1
    LTDebt / Equity 57
    Alpha -0.12
    Beta 1.31

    Sotac Pharmaceuticals Ltd

    Owner NameApr-23
    Promoters 72.85%
    Foreign Portfolio Investors 12.88%
    Individual Investors 8.19%
    Others 6.08%

    Sotac Pharmaceuticals Ltd Management

    Name Designation
    Mr. Sharadkumar Dashrathbhai Patel Chairman & Managing Director
    Mr. Dineshkumar Babulal Gelot Whole Time Director
    Mr. Vishalkumar Devrajbhai Patel Executive Director
    Mr. Chetankumar Bachubhai Patel Executive Director
    Ms. Nidhiben Patel Ind. Non-Executive Director
    Ms. Hetal Umangbhai Shah Ind. Non-Executive Director
    Ms. Heena Viral Patel Ind. Non-Executive Director

    Sotac Pharmaceuticals Ltd Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Sotac Pharmaceuticals Ltd Corporate Action

    Date Purpose Remarks
    2023-05-29 Audited Results
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Sotac Pharmaceuticals Ltd FAQs

    What is Share Price of Sotac Pharmaceuticals Ltd ?

    Sotac Pharmaceuticals Ltd share price is ₹120 As on 25 September, 2023 | 14:44

    What is the Market Cap of Sotac Pharmaceuticals Ltd ?

    The Market Cap of Sotac Pharmaceuticals Ltd is ₹132.6 Cr As on 25 September, 2023 | 14:44

    What is the P/E ratio of Sotac Pharmaceuticals Ltd ?

    The P/E ratio of Sotac Pharmaceuticals Ltd is As on 25 September, 2023 | 14:44

    What is the PB ratio of Sotac Pharmaceuticals Ltd ?

    The PB ratio of Sotac Pharmaceuticals Ltd is 13 As on 25 September, 2023 | 14:44

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Enter Mobile Number

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.